Gulf International Bank (UK)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $747K | Hold |
5,950
| – | – | 0.03% | 493 |
|
|
2025
Q1 | $658K | Sell |
5,950
-1,745
| -23% | -$193K | 0.02% | 530 |
|
|
2024
Q4 | $1.05M | Hold |
7,695
| – | – | 0.03% | 476 |
|
|
2024
Q3 | $886K | Sell |
7,695
-373
| -5% | -$42.9K | 0.02% | 514 |
|
|
2024
Q2 | $1.11M | Hold |
8,068
| – | – | 0.03% | 463 |
|
|
2024
Q1 | $1.11M | Hold |
8,068
| – | – | 0.03% | 477 |
|
|
2023
Q4 | $1.06M | Sell |
8,068
-1,048
| -11% | -$138K | 0.03% | 472 |
|
|
2023
Q3 | $1.03M | Sell |
9,116
-763
| -8% | -$85.8K | 0.03% | 479 |
|
|
2023
Q2 | $931K | Sell |
9,879
-2,821
| -22% | -$266K | 0.02% | 540 |
|
|
2023
Q1 | $1.29M | Sell |
12,700
-720
| -5% | -$72.9K | 0.03% | 514 |
|
|
2022
Q4 | $1.6M | Hold |
13,420
| – | – | 0.03% | 508 |
|
|
2022
Q3 | $1.43M | Hold |
13,420
| – | – | 0.03% | 519 |
|
|
2022
Q2 | $1.32M | Hold |
13,420
| – | – | 0.02% | 540 |
|
|
2022
Q1 | $1.26M | Hold |
13,420
| – | – | 0.02% | 568 |
|
|
2021
Q4 | $1.14M | Hold |
13,420
| – | – | 0.02% | 592 |
|
|
2021
Q3 | $1.29M | Hold |
13,420
| – | – | 0.02% | 608 |
|
|
2021
Q2 | $1.31M | Hold |
13,420
| – | – | 0.02% | 619 |
|
|
2021
Q1 | $1.31M | Sell |
13,420
-6,300
| -32% | -$613K | 0.02% | 607 |
|
|
2020
Q4 | $1.89M | Sell |
19,720
-200
| -1% | -$19.2K | 0.02% | 561 |
|
|
2020
Q3 | $1.92M | Hold |
19,920
| – | – | 0.03% | 503 |
|
|
2020
Q2 | $2.43M | Hold |
19,920
| – | – | 0.04% | 434 |
|
|
2020
Q1 | $1.72M | Hold |
19,920
| – | – | 0.03% | 456 |
|
|
2019
Q4 | $2.14M | Buy |
+19,920
| New | +$2.14M | 0.03% | 496 |
|